What’s in news?
DCGI set out for an ambitious target to increase exports of drugs to 60 per cent.
- A two-day international regulator meet was organized by Pharmaceutical Exports Promotion Council of India.
- The meet is aimed at “International Regulatory Convergence to Promote Accessibility and Affordability of Quality Medicines”.
- The Drugs Controller General of India (DCGI) planned a target to increase exports of drugs to 60 per cent from existing 40 per cent.
- This can be achieved by improving quality and efficiency and enhancing ease of doing business.
- The initiative which will be implemented in different phases and focusing on different aspects of the regulatory process.
- If India continues with its growth momentum as it has now, it’s contribution to the global drug market can be increase by 50 per cent in the next three years.
- India produces the world’s most affordable medicines and increasing supply was doable provided quality standards improve.
- India recorded with 21.7 per cent growth in July 2019. The cumulative growth of Indian exports for the period of April-July 2019 is 13 per cent.
- To ensure transparency in the field, regulatory approvals including product certification will soon be processed online for both domestic and global firms, as currently the process is partially online.
- Regulatory staff has been trained on several aspects including medical devices, e-governance, bioequivalent and bio-availability studies to improve the overall efficiency of the regulatory department.
- In the “International Regulators Meet”, which was organized by Pharmexcil with the support of Ministry of Commerce & Industry, regulators from about 25 countries are participating.
Drug Controller General of India (DCGI):
- Works under the Ministry of Health & Family Welfare.
- VG Somani, appointed as the DCGI by GoI in the month of August 2019.
DCGI lays down the standard and quality of manufacturing, selling, import and distribution of drugs in India.
- Acting as appellate authority in case of any dispute regarding the quality of drugs.
- Preparation and maintenance of national reference standard.
- To bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.
- Training of Drug Analysts deputed by State Drug Control Laboratories and other Institutions.
- Analysis of Cosmetics received as survey samples from CDSCO (central drug standard control organisation).
Links to note: